Account Ml rr-s2 cda intermediate 1
- Catalog No. :
- ACAZIW134
- CAS No. :
- 1638751-29-7
- Molecular Formula :
- C32H52N10O10P2S2Si2
- Molecular Weight :
- 919.08
IUPAC Name:(2S,5R,7R,8R,10R,12aR,14R,15R,15aR)-7,14-bis(6-amino-9H-purin-9-yl)-15,16-bis((tert-butyldimethylsilyl)oxy)-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$1057.00Login to see priceInquiryInquiry
1g98%$2641.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Ml rr-s2 cda intermediate 1 |
|---|---|
| IUPAC Name | (2S,5R,7R,8R,10R,12aR,14R,15R,15aR)-7,14-bis(6-amino-9H-purin-9-yl)-15,16-bis((tert-butyldimethylsilyl)oxy)-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide |
| Molecular Formula | C32H52N10O10P2S2Si2 |
| Molecular Weight | 919.08 |
| SMILES | CC(C)(C)[Si](C)(C)OC1[C@H]2O[P@](=O)(S)OC[C@H]3O[C@@H](N4C=NC5=C(N)N=CN=C54)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[P@@](=O)(S)OC[C@H]1O[C@H]2N1C=NC2=C(N)N=CN=C21 |
| InChI Key | FKOZSOBEVWEYLJ-HOLMKKPHSA-N |
| Synonym | ML RR-S2 CDA intermediate 1;Adenosine, [P(S)]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-5'-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3'→5')-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, cyclic nucleotide |
| CAS No. | 1638751-29-7 |
Safety Data
- Pictogram
- Signal Word
- Achtung
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501
Synthetic Route by SureRoute
2. ACAZIW134 Molecular Building Block Synthetic Route
(2R,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7,14-Bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide
(2R,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7,14-Bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide disodium salt
(2R,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7,14-Bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide diammonium salt